NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
114 hedge funds and large institutions have $730M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
Holders
114
Holding in Top 10
5
Calls
$41K
Puts
–
Top Buyers
| 1 | +$13M | |
| 2 | +$8.25M | |
| 3 | +$7.18M | |
| 4 |
Morgan Stanley
New York
|
+$4.37M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$3.75M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$8.41M | |
| 3 | -$8.18M | |
| 4 |
Millennium Management
New York
|
-$1.78M |
| 5 |
Two Sigma Investments
New York
|
-$1.36M |